These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

396 related articles for article (PubMed ID: 16951165)

  • 1. p27Kip1 repression of ErbB2-induced mammary tumor growth in transgenic mice involves Skp2 and Wnt/beta-catenin signaling.
    Hulit J; Lee RJ; Li Z; Wang C; Katiyar S; Yang J; Quong AA; Wu K; Albanese C; Russell R; Di Vizio D; Koff A; Thummala S; Zhang H; Harrell J; Sun H; Muller WJ; Inghirami G; Lisanti MP; Pestell RG
    Cancer Res; 2006 Sep; 66(17):8529-41. PubMed ID: 16951165
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cyclin D1 induction of cellular migration requires p27(KIP1).
    Li Z; Jiao X; Wang C; Ju X; Lu Y; Yuan L; Lisanti MP; Katiyar S; Pestell RG
    Cancer Res; 2006 Oct; 66(20):9986-94. PubMed ID: 17047061
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Loss of the cell cycle inhibitors p21(Cip1) and p27(Kip1) enhances tumorigenesis in knockout mouse models.
    Jackson RJ; Adnane J; Coppola D; Cantor A; Sebti SM; Pledger WJ
    Oncogene; 2002 Dec; 21(55):8486-97. PubMed ID: 12466968
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Expression of the F-box protein SKP2 induces hyperplasia, dysplasia, and low-grade carcinoma in the mouse prostate.
    Shim EH; Johnson L; Noh HL; Kim YJ; Sun H; Zeiss C; Zhang H
    Cancer Res; 2003 Apr; 63(7):1583-8. PubMed ID: 12670908
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cooperating oncogenic events in murine mammary tumorigenesis: assessment of ErbB2, mutant p53, and mouse mammary tumor virus.
    Zelazny E; Li B; Anagnostopoulos AM; Coleman A; Perkins AS
    Exp Mol Pathol; 2001 Jun; 70(3):183-93. PubMed ID: 11417997
    [TBL] [Abstract][Full Text] [Related]  

  • 6. High expression of S-phase kinase-interacting protein 2, human F-box protein, correlates with poor prognosis in oral squamous cell carcinomas.
    Kudo Y; Kitajima S; Sato S; Miyauchi M; Ogawa I; Takata T
    Cancer Res; 2001 Oct; 61(19):7044-7. PubMed ID: 11585732
    [TBL] [Abstract][Full Text] [Related]  

  • 7. STAT1 represses Skp2 gene transcription to promote p27Kip1 stabilization in Ras-transformed cells.
    Wang S; Raven JF; Koromilas AE
    Mol Cancer Res; 2010 May; 8(5):798-805. PubMed ID: 20407011
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Wnt pathway component LEF1 mediates tumor cell invasion and is expressed in human and murine breast cancers lacking ErbB2 (her-2/neu) overexpression.
    Nguyen A; Rosner A; Milovanovic T; Hope C; Planutis K; Saha B; Chaiwun B; Lin F; Imam SA; Marsh JL; Holcombe RF
    Int J Oncol; 2005 Oct; 27(4):949-56. PubMed ID: 16142310
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The role of Ink4a/Arf in ErbB2 mammary gland tumorigenesis.
    D'Amico M; Wu K; Di Vizio D; Reutens AT; Stahl M; Fu M; Albanese C; Russell RG; Muller WJ; White M; Negassa A; Lee HW; DePinho RA; Pestell RG
    Cancer Res; 2003 Jun; 63(12):3395-402. PubMed ID: 12810676
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Functional analysis of cyclin D2 and p27(Kip1) in cyclin D2 transgenic mouse mammary gland during development.
    Kong G; Chua SS; Yijun Y; Kittrell F; Moraes RC; Medina D; Said TK
    Oncogene; 2002 Oct; 21(47):7214-25. PubMed ID: 12370811
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cytoplasmic p27 is oncogenic and cooperates with Ras both in vivo and in vitro.
    Serres MP; Zlotek-Zlotkiewicz E; Concha C; Gurian-West M; Daburon V; Roberts JM; Besson A
    Oncogene; 2011 Jun; 30(25):2846-58. PubMed ID: 21317921
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Involvement of p27(KIP1) degradation by Skp2 in the regulation of proliferation in response to wounding of corneal epithelium.
    Yoshida K; Nakayama K; Nagahama H; Harada T; Harada C; Imaki J; Matsuda A; Yamamoto K; Ito M; Ohno S; Nakayama K
    Invest Ophthalmol Vis Sci; 2002 Feb; 43(2):364-70. PubMed ID: 11818378
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Tumor progression induced by the loss of E-cadherin independent of beta-catenin/Tcf-mediated Wnt signaling.
    Herzig M; Savarese F; Novatchkova M; Semb H; Christofori G
    Oncogene; 2007 Apr; 26(16):2290-8. PubMed ID: 17043652
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Correlation of Skp2 and P27kip1 protein expression and clinicopathological features of prostate cancer].
    Zheng XY; Ding W; Xie LP; Chen ZD
    Ai Zheng; 2004 Feb; 23(2):215-8. PubMed ID: 14960249
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Soy isoflavone genistein upregulates epithelial adhesion molecule E-cadherin expression and attenuates beta-catenin signaling in mammary epithelial cells.
    Su Y; Simmen RC
    Carcinogenesis; 2009 Feb; 30(2):331-9. PubMed ID: 19073877
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Metalloproteinase axes increase beta-catenin signaling in primary mouse mammary epithelial cells lacking TIMP3.
    Hojilla CV; Kim I; Kassiri Z; Fata JE; Fang H; Khokha R
    J Cell Sci; 2007 Mar; 120(Pt 6):1050-60. PubMed ID: 17327279
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Skp2-mediated p27(Kip1) degradation during S/G2 phase progression of adipocyte hyperplasia.
    Auld CA; Fernandes KM; Morrison RF
    J Cell Physiol; 2007 Apr; 211(1):101-11. PubMed ID: 17096381
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Modified p27 Kip1 is efficient in suppressing HER2-mediated tumorigenicity.
    Yang HY; Yang H; Zhao R; Lee MH
    J Cell Biochem; 2006 May; 98(1):128-38. PubMed ID: 16365885
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Reduced E-cadherin expression contributes to the loss of p27kip1-mediated mechanism of contact inhibition in thyroid anaplastic carcinomas.
    Motti ML; Califano D; Baldassarre G; Celetti A; Merolla F; Forzati F; Napolitano M; Tavernise B; Fusco A; Viglietto G
    Carcinogenesis; 2005 Jun; 26(6):1021-34. PubMed ID: 15718252
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Oncogenic properties and prognostic implications of the ubiquitin ligase Skp2 in cancer.
    Hershko DD
    Cancer; 2008 Apr; 112(7):1415-24. PubMed ID: 18260093
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 20.